​Mountain Arnica — Arnica montana (Flores)

Mountain Arnica — Arnica montana (Flores)

Product Name: Арника горная, Arnica montana, Bergwohlverleih, Árnica montana, Arnica des montagnes, أرنيكا جبلية, อาร์นิกา มอนแทนา, Arnika tog‘, Арника тоо, Dağ arnikası, Арникаи кӯҳӣ, Kalnų arnika, Kalnu arnika, Арніка гірська, Dağ arnikası, ארניקה מונטנה

Synonyms: Арника, арника цветочная, арника настоящая, горная арника, травянка, волчья трава, горный табак, горная ромашка; Arnica flower, Mountain arnica, Leopard's bane; Echte Arnika, Bergarnika, Wohlverleih; Árnica verdadera, Tabaco de montaña; Arnique vraie, Tabac des Vosges; الأرنيكا, نبتة الذئب, تبغ الجبل; อาร์นิกา, ยาอาร์นิกา, ยาหม่องอาร์นิกา

Parts Used: rhizomes, roots, herb, leaves, stems, seeds, flowers

Main Indications for Arnica montana Use: Traumatic soft tissue bruises, hematomas, myalgia, arthralgia, osteoarthritis, rheumatoid arthritis, varicose veins, thrombophlebitis, peripheral neuropathies, superficial skin inflammation, infectious-inflammatory diseases of the oral cavity, gingivitis, periodontitis, stomatitis, bleeding gums.

Use of Arnica montana in mixtures and complexes: Spinal osteochondrosis, chronic bronchitis, chronic sinusitis, climacteric syndrome, hypertension, migraine, consequences of traumatic brain injury, varicocele, endometriosis, trophic ulcers, multiple sclerosis.

Pharmacological Properties of Arnica montana: anti-inflammatory, analgesic, capillaroprotective, anti-edematous, antiseptic, immunomodulating, wound-healing, antibacterial, hemostatic, microcirculation-stimulating, venotonic, antioxidant, spasmolytic, antifungal, granulation-stimulating, resorptive, regenerative.

Dosage of Pharmaceutical Forms — Arnica montana

Powder — Arnica montana

Indications (Powder): Traumatic soft tissue bruises, post-traumatic hematomas, myalgia, knee osteoarthritis, rheumatoid arthritis, varicose veins, subcutaneous thrombophlebitis, infectious-inflammatory gum diseases, gingivitis, periodontitis.

Standard Dosage (Powder): For external use of powder: dissolve 2 grams of powder in 100 milliliters of warm boiled water, use as a compress or bandage on the affected area twice a day, duration of course — 5–7 days. For local use in the oral cavity: dilute 1 gram of powder in 200 milliliters of water, use as a rinse up to 3 times a day.

Enhanced Dosage (Powder): For extensive hematomas, severe forms of osteoarthritis, purulent periodontitis: use 3 grams of powder per 100 milliliters of water, apply as wet bandages three times a day. Duration of use should not exceed 10 days.

Maximum Dosage (Powder): Maximum permissible concentration — 5 grams of powder per 100 milliliters of water, no more than one application per day and no longer than 5 days in a row. Strict medical supervision is recommended for use in acute forms of rheumatoid arthritis or phlebothrombosis.

Preventive Dosage (Powder): For patients with chronic varicose veins of the lower extremities, hypertrophic gingivitis, frequent bruises due to vascular fragility — 1 gram of powder per 150 milliliters of water, compresses or rinses once a day, course — 7 days monthly. Recommended for elderly patients and athletes during periods of intense exertion.

Pediatric Dosage (Powder): External use is permissible in children over 6 years of age and weighing more than 20 kilograms. Dilute 0.5 grams of powder in 200 milliliters of water, use only locally, once a day for no more than 3 days in a row. Not recommended for children under 6 years of age and in the presence of skin damage.

Contraindications (Powder): Deep skin damage, eczema, individual hypersensitivity to plants of the Asteraceae family. No data on contraindications scientifically registered for pregnancy, lactation and pediatric practice, use requires caution and medical supervision.

Side Effects (Powder): In case of overdose, contact dermatitis, burning, hyperemia, allergic reactions in the form of rash and itching are possible. Cases of local tissue necrosis have been recorded when using high concentration powder on open wounds.

Adjustment for Patient Body Weight: For body weight below 60 kilograms, it is recommended to reduce the concentration of powder by 25%, especially with repeated applications. For weight above 90 kilograms, a dose increase of 10–15% is possible, but with mandatory assessment of skin condition.

Preparation method (Powder): To obtain 100 grams of powder, 120 grams of dried mountain arnica flowers are used. The flowers are dried at a temperature not exceeding 45 degrees Celsius until completely dry. Then they are ground into a fine powder using a ceramic mortar or an electric mill made of inert material. The powder is sifted through a sieve with a mesh size of no more than 0.3 millimeters. Stored in a tightly closed glass container.

Storage Conditions and Shelf Life (Powder): Store in an airtight glass container in a dark, dry place at a temperature of 5 to 25 degrees Celsius, away from sources of electromagnetic radiation. Shelf life — up to 12 months. After opening, use within 60 days, avoid contact with moisture.

Dry Extract — Arnica montana

Indications (Dry Extract): Post-traumatic hematomas, myalgia, tendinitis, osteoarthritis, varicose veins, chronic gingivitis, periodontitis, stomatitis, chronic venous insufficiency, trigeminal neuralgia, superficial skin inflammation.

Standard Dosage (Dry Extract): External use: dilute 1 gram of dry extract in 50 milliliters of warm water, apply to the affected area of skin or use for compresses 2 times a day. Mouth rinses: 0.5 grams of extract per 100 milliliters of water, 2–3 times a day. Course — up to 10 days.

Enhanced Dosage (Dry Extract): For severe forms of periodontitis, thrombophlebitis, arthralgia — use 2 grams of extract per 50 milliliters of water, applications 3 times a day. Course duration — up to 7 days under medical supervision.

Maximum Dosage (Dry Extract):) Use of up to 3 grams of dry extract per day on a limited area of skin is permissible, no more than 5 days in a row. Used for severe inflammation of soft tissues, severe bruises, provided there is no damage to the skin.

Preventive Dosage (Dry Extract): For patients with chronic varicose veins, a tendency to bleeding gums and recurrent bruises — 0.5 grams of extract in 100 milliliters of water, compresses or rinses once a day, 5–7 days monthly. Suitable for the elderly, athletes, patients with vascular pathology.

Pediatric Dosage (Dry Extract):) Local use is allowed for children over 6 years of age with body weight more than 20 kilograms. A solution with a concentration of 0.25 grams of extract per 100 milliliters of water is used, once a day, no more than 3 days in a row. Do not apply to damaged skin.

Contraindications (Dry Extract): Open wounds, eczematous lesions, allergy to plants of the Asteraceae family. Data on safety during pregnancy, lactation and in children under 6 years of age have not been scientifically confirmed — a doctor's consultation is necessary.

Side Effects (Dry Extract): Skin rashes, contact dermatitis, irritation of mucous membranes when exceeding the concentration, allergic reactions, burning sensation have been recorded.

Adjustment for Patient Body Weight: For patients with body weight below 60 kilograms — it is recommended to reduce the concentration of the solution by 20–25%. With weight above 90 kilograms, an increase in concentration by 10% is permissible, but with short-term use.

Preparation method (Dry Extract): To obtain 100 grams of dry extract, 500 grams of ground dried arnica flowers are used. Extraction is carried out with 70% ethanol at a temperature of 40–45 degrees Celsius for 48 hours. Then the liquid is evaporated at a temperature not exceeding 50 degrees to obtain a thick extract. Drying is carried out by vacuum drying or lyophilization to obtain a dry powdery substance. The finished dry extract is sifted and packaged in airtight jars.

Storage Conditions and Shelf Life (Dry Extract): Store in an airtight dark glass or foil-packaged container, at a temperature of 5 to 25 degrees Celsius, in a dry place, away from sources of heat, moisture and electromagnetic radiation. Shelf life — up to 24 months. After opening, use within 60 days.

Tincture — Arnica montana

Indications (Tincture): Hematomas, myalgia, arthralgia, tendinitis, rheumatoid arthritis, osteoarthritis, varicose veins, thrombophlebitis, chronic gingivitis, periodontitis, trophic ulcers, trigeminal neuralgia.

Standard Dosage (Tincture): Externally: dilute 20 drops of tincture in 100 milliliters of boiled water, use as compresses 2 times a day. Rinses: 10 drops per 100 milliliters of water, 2 times a day. Course of treatment — 7–10 days.

Enhanced Dosage (Tincture): For pronounced venous insufficiency, acute joint inflammation, chronic periodontitis — use 30 drops per 100 milliliters of water for compresses or rinses, up to 3 times a day. Duration — no more than 7 days under the supervision of a specialist.

Maximum Dosage (Tincture): Maximum permissible dose: 40 drops of tincture per day, diluted in water, for severe hematomas and severe joint pain. External use is allowed once a day, course — no more than 5 days. Internal use is unacceptable due to toxicity.

Preventive Dosage (Tincture): For patients with chronic varicose veins, a tendency to microhemorrhages and recurrent inflammatory gum diseases — 5–10 drops per 100 milliliters of water, compresses or rinses once a day, course — 5 days monthly. Suitable for elderly patients and persons in the period of post-load recovery.

Pediatric Dosage (Tincture): Not recommended for children under 12 years of age. From 12 years of age — only external use: 5 drops per 100 milliliters of water, no more than once a day, course up to 3 days. Internal use is strictly prohibited.

Contraindications (Tincture): Open wounds, individual intolerance, eczema, atopic dermatitis. Internal use is contraindicated. No data on safety during pregnancy, lactation and in children under 12 years of age have been registered — use with caution.

Side Effects (Tincture): Contact dermatitis, hyperemia, burning sensation, systemic allergic reactions when exceeding the dosage or applying to damaged skin. Cases of nausea and headache have been recorded with accidental ingestion.

Adjustment for Patient Body Weight: With body weight below 60 kilograms, it is recommended to reduce the concentration by 25%. With weight above 90 kilograms, an increase in concentration by 10% is permissible, while maintaining the frequency of use.

Preparation method (Tincture): To prepare 100 milliliters of tincture, use 20 grams of ground dried arnica flowers and 100 milliliters of 70% ethyl alcohol. The flowers are placed in a glass container, poured with alcohol, sealed tightly and infused in a dark place at a temperature of 20–25 degrees Celsius for 10 days. The mixture is shaken daily. After infusion, the liquid is filtered through thick cheesecloth and poured into a dark glass bottle.

Storage Conditions and Shelf Life (Tincture): Store in a tightly closed dark glass bottle, at a temperature of 5 to 25 degrees Celsius, away from sources of light and heat, in a shielded place. Shelf life — up to 36 months. After opening, use within 90 days.

Oil Infusion — Arnica montana

Indications (Oil Infusion): Hematomas, soft tissue bruises, myalgia, tendinitis, osteoarthritis, varicose veins, thrombophlebitis, sciatic neuralgia, chronic venous insufficiency, inflammation of the skin without violation of integrity, superficial trophic disorders.

Standard Dosage (Oil Infusion): Apply a thin layer to the affected area 2 times a day. Light massage for 2–3 minutes helps to increase absorption. Course — 7–10 days.

Enhanced Dosage (Oil Infusion): For severe pain syndromes, joint inflammation, chronic edema and neuralgia: apply up to 3 times a day, rubbing into the skin until completely absorbed. Course duration — up to 14 days.

Maximum Dosage (Oil Infusion): Maximum — up to 4 applications per day on limited areas of skin (up to 10% of body area), for no more than 7 days in a row. Medical supervision is recommended when used in patients with vascular and rheumatological pathologies.

Preventive Dosage (Oil Infusion): Once a day on areas with chronic venous load, a tendency to edema and muscle strain (for example, calf muscles, lower back in the elderly, knee joints in athletes). Course — 5 days monthly.

Pediatric Dosage (Oil Infusion): Permitted from 3 years of age in the absence of skin damage. The oil is applied once a day in a thin layer, only to intact skin, course — no more than 3 days. The oil must be filtered, without residues of plant material.

Contraindications (Oil Infusion): Individual intolerance, skin damage, eczema, allergic dermatitis. No data on contraindications scientifically registered for pregnancy, lactation and children under 3 years of age — use is permissible only in the absence of skin disorders and under medical supervision.

Side Effects (Oil Infusion): Contact dermatitis, erythema, itching, peeling, allergic rashes. When applied to large areas, systemic effects are possible with increased pressure, headache and weakness.

Adjustment for Patient Body Weight: For patients with body weight less than 60 kilograms, it is recommended to limit the area of application to 5% of the body surface. With weight over 90 kilograms, an increase in the area of application to 15% is permissible, while observing the standard frequency of application.

Preparation method (Oil Infusion): To prepare 100 grams of infusion, take 30 grams of dried and ground arnica flowers and 100 milliliters of organic coconut oil. The oil is pre-melted in a water bath to 40–45 degrees Celsius. The raw material is placed in a glass container, poured with oil and kept in a water bath for 3 hours at a temperature of 45 degrees, then infused for 5 days in a dark, warm place. The mixture is filtered through cheesecloth. The finished infusion is poured into a sterile dark glass jar.

Storage Conditions and Shelf Life (Oil Infusion): Store in an airtight dark glass container, at a temperature of 10 to 25 degrees Celsius, away from direct sunlight and heat sources. Avoid storing near electromagnetic sources. Shelf life — 6 months. After opening, use within 30 days.

Ointment — Arnica montana

Indications (Ointment): Traumatic bruises, myalgia, arthralgia, osteoarthritis, tendinitis, varicose veins, thrombophlebitis, sciatic neuralgia, superficial inflammatory dermatoses, localized edema, chronic venous insufficiency.

Standard Dosage (Ointment): Apply a thin layer to clean dry skin 2 times a day, with light massaging movements. Avoid damaged skin areas. Course duration — 7–10 days.

Enhanced Dosage (Ointment): For pronounced inflammatory manifestations and pain syndrome — up to 3 applications per day. The use of an occlusive dressing on the knee joints, lower back or neck for arthralgia and neuralgia is allowed. Course — up to 14 days.

Maximum Dosage (Ointment): Maximum permissible use — 4 times a day on areas of skin not exceeding 15% of the total body area, no longer than 7 days in a row. Used in conditions of acute pain or edema after injuries.

Preventive Dosage (Ointment): Recommended for chronic venous insufficiency, for the prevention of joint inflammation in the elderly and athletes: 1 application per day on the calf muscles, lumbar region or knee joint area. Course — 5 days in a row once a month.

Pediatric Dosage (Ointment): External use is allowed from 6 years of age. Application once a day in a thin layer on a limited area of skin is permissible, course — no more than 3 days. Use under bandages is not recommended. Use is not indicated in children with body weight less than 20 kilograms.

Contraindications (Ointment): Open wounds, weeping dermatoses, allergy to plants of the Asteraceae family, active skin infections. No scientific data on contraindications during pregnancy, lactation and in early childhood have been registered — use under medical supervision.

Side Effects (Ointment): Contact dermatitis, itching, rash, burning have been recorded. With prolonged use on large areas, systemic effects are possible — dizziness, nausea, weakness. Symptoms disappear upon discontinuation of use.

Adjustment for Patient Body Weight: With body weight below 60 kilograms, it is recommended to limit the area of application to 5% of the body surface and reduce the frequency of use to once a day. Patients with weight above 90 kilograms can use the drug on an area of up to 20% of the body surface while maintaining the frequency.

Preparation method (Ointment): To prepare 100 grams of ointment, you need: dry arnica extract — 5 grams, coconut oil — 60 grams, beeswax — 20 grams, shea butter — 10 grams, lavender essential oil — 5 grams. Coconut oil and shea butter are melted in a water bath at a temperature of 45 degrees. Dry arnica extract is introduced into the mixture, then beeswax. After complete dissolution of the components and cooling to 35 degrees, essential oil is introduced. The mixture is thoroughly mixed until a homogeneous mass is obtained and poured into sterile jars.

Storage Conditions and Shelf Life (Ointment): Store in a tightly closed glass container at a temperature of 5 to 20 degrees Celsius, away from sources of light, heat and electromagnetic radiation. Shelf life — up to 6 months. After opening, use within 30 days. Avoid contamination of the contents of the jar.

Cream-Balm — Arnica montana

Indications (Cream-Balm): Myalgia, arthralgia, tendinitis, bruises, post-traumatic hematomas, chronic osteoarthritis, varicose veins, thrombophlebitis, sciatic neuralgia, muscle tension, swelling of the lower extremities, inflammation of the ligamentous apparatus.

Standard Dosage (Cream-Balm): Apply a thin layer to clean skin 2 times a day, with light massaging movements, until completely absorbed. Course of treatment — 7–10 days.

Enhanced Dosage (Cream-Balm): For severe pain, inflammation and edema — apply up to 3 times a day. Use under a compress (no more than 2 hours in a row) on the area of joints or muscles is possible. Course — up to 14 days under the supervision of a specialist.

Maximum Dosage (Cream-Balm): Maximum — 4 applications per day on areas of skin not exceeding 20% of the body surface. Course duration — no more than 7 days. Used for severe bruises, sports overload and inflammation of deep muscles.

Preventive Dosage (Cream-Balm): For persons with chronic joint diseases, varicose veins and after physical overload — once a day on problem areas (lower back, shins, shoulder girdle), a course of 5 days in a row monthly. Suitable for the elderly, athletes and persons with professions associated with prolonged standing work.

Pediatric Dosage (Cream-Balm): Use is permissible from 6 years of age. Apply once a day to a limited area of skin for bruises and muscle strain. Course — no more than 3 days. Use under a bandage is prohibited. Not recommended for children with body weight less than 20 kilograms.

Contraindications (Cream-Balm): Individual intolerance, skin damage, eczema, psoriasis in the acute stage. No scientific data on safety during pregnancy, lactation and in children under 6 years of age are available. Use is possible only on the recommendation of a physician.

Side Effects (Cream-Balm): Contact dermatitis, local redness, itching, peeling. With prolonged use, allergic reactions are possible. In rare cases — headache and general weakness when applied to extensive areas.

Adjustment for Patient Body Weight: With weight less than 60 kilograms, limit the area of application and frequency — no more than once a day on areas up to 5% of the body surface. Patients with body weight over 90 kilograms can increase the area of treatment to 25%, while maintaining the standard frequency.

Preparation method (Cream-Balm): To prepare 100 grams of cream-balm, take: liquid arnica extract — 10 grams, coconut oil — 40 grams, emulsifier (beeswax) — 10 grams, lavender hydrolate — 30 grams, vegetable glycerin — 5 grams, rosemary essential oil — 5 grams. The oil and water phases are heated to 45 degrees Celsius separately, then mixed with constant stirring. After thickening at 30 degrees, essential oil is introduced. The finished cream is packaged in sterile jars.

Storage Conditions and Shelf Life (Cream-Balm): Store at a temperature of 5 to 20 degrees Celsius, in a place protected from light and heat, away from sources of electromagnetic radiation. Shelf life — 4 months. After opening, use within 30 days, store with a tightly closed lid.

Cream — Arnica montana

Indications (Cream): Soft tissue bruises, hematomas, myalgia, arthralgia, osteoarthritis, varicose veins, thrombophlebitis, localized edema, chronic lymphedema, tendon inflammation, muscle strain, intercostal and lumbar neuralgia.

Standard Dosage (Cream): Apply 2 times a day to clean skin in the affected area, in a thin layer, with light rubbing. Avoid damaged areas and mucous membranes. Course — from 5 to 10 days.

Enhanced Dosage (Cream): For severe pain syndrome, edema, post-traumatic inflammation — up to 3 applications per day. Application of a warm dry compress after application is possible. Duration of use — up to 14 days under medical supervision.

Maximum Dosage (Cream): No more than 4 applications per day on areas of skin up to 20% of the total body area. Used for severe bruises, edema and neuralgia, exclusively externally. Duration — no more than 7 days.

Preventive Dosage (Cream): Recommended for chronic venous disorders, a predisposition to bruises and edema, after physical exertion and prolonged standing. Apply once a day for 3–5 days on the calf muscles or lumbar region. Course — monthly.

Pediatric Dosage (Cream):) External use is permissible from 6 years of age. Once a day on a small area of skin (up to 5 cm²), for hematomas and bruises. Course — no more than 3 days. Use under bandages and on extensive areas is not allowed.

Contraindications (Cream): Skin damage, eczema, allergy to plants of the Asteraceae family, weeping dermatoses. No scientific data on safety during pregnancy, lactation and in early childhood have been registered — requires medical supervision.

Side Effects (Cream): Itching, burning, hyperemia, contact dermatitis. When applied to damaged skin — increased pain, systemic allergic reactions are possible with prolonged and extensive use.

Adjustment for Patient Body Weight: For patients with body weight up to 60 kilograms, it is recommended to apply the cream to a smaller area of skin (up to 5% of the body surface) and reduce the frequency to 1–2 times a day. With body weight more than 90 kilograms, an increase in the area of application to 25% is possible while maintaining the frequency.

Preparation method (Cream): To prepare 100 grams of cream, you need: dry arnica extract — 8 grams, coconut oil — 40 grams, emulsifier (cetearyl glucoside) — 5 grams, purified water — 40 grams, eucalyptus essential oil — 2 grams, plant-based preservative (rosemary extract) — 5 grams. The oil and water phases are heated to 40–45 degrees, then slowly combined with constant stirring until a homogeneous emulsion is obtained. After cooling to 30 degrees, essential oil is introduced. Packaged in sterile plastic or glass tubes.

Storage Conditions and Shelf Life (Cream): Store in a dark place at a temperature of 5 to 20 degrees Celsius. Avoid exposure to direct sunlight and high temperatures. Store away from electromagnetic sources. Shelf life — up to 6 months. After opening — no more than 30 days.

Toxicity and Biosafety of Arnica montana

Arnica montana contains pharmacologically active compounds, including helenalin and its esters, which have pronounced biological activity and moderate toxicity with systemic administration. Studies on animals have shown that the LD₅₀ for helenalin with intravenous administration in mice is about 3–5 mg/kg, which indicates potential danger in case of overdose and the impossibility of internal use without strict standardization and control.

With oral administration of arnica extract, the LD₅₀ in rats ranged from 50 to 100 mg/kg, depending on the degree of purification of the extract. However, external use — in the form of ointments, infusions, infusions and creams — is recognized as safe when following the recommended dosages and duration of use. With prolonged or uncontrolled use on extensive areas of skin, systemic accumulation of helenalin is possible, which determines the risk of hepatotoxicity and nephrotoxicity.

The bioavailability of active components of arnica with external use is low, systemic absorption is minimal. However, with violation of the skin barrier (wounds, dermatitis), bioavailability can increase sharply, which increases the risk of toxic effects.

In vitro studies have also shown that arnica extracts can cause cytotoxic effects at high concentrations on fibroblasts and epithelial cells, which requires caution when used in cosmetology on damaged skin.

Reference: https://pubmed.ncbi.nlm.nih.go... – Toxicity of sesquiterpene lactones isolated from Arnica montana L.

Pharmacodynamics — Arnica montana

Arnica montana demonstrates a wide range of pharmacodynamic effects due to the presence of biologically active substances in its composition, primarily sesquiterpene lactones (in particular, helenalin), flavonoids, phenolic acids, coumarins and essential oils. The pharmacological properties of this taxon cover systemic and local levels of action, affecting nervous, vascular, immune, skin and connective tissue regulation.

The most studied components — helenalin and its derivatives — exhibit pronounced activity against inflammatory mediators. They are able to inhibit the production of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) by inhibiting NF-κB-dependent transcription, as well as suppress the activity of cyclooxygenase-2 (COX-2), which leads to a decrease in prostaglandin synthesis. These effects are realized both in local tissues and systemically, subject to absorption.

Arnica flavonoids, including quercetin, isorhamnetin and their glycosides, have pronounced antioxidant activity, contributing to the utilization of free radicals and the restoration of redox homeostasis in the focus of inflammation. The antioxidant effect is also manifested at the level of membrane structures, stabilizing lipid layers and preventing lipid peroxidation.

Arnica components affect the vascular system due to venotonic and capillaroprotective action. An increase in the tone of the smooth muscles of the venous wall, a decrease in vascular permeability, and an increase in lymph drainage function have been noted. Such effects are partially associated with the inhibition of hyaluronidase and the stabilization of the capillary basement membrane.

At the skin level, arnica has a stimulating effect on fibroblasts and the proliferation of granulation tissue cells, which is confirmed by in vitro models of skin regeneration. Coumarins and flavonoids enhance angiogenesis in damaged tissues, activate collagen synthesis and improve microcirculation.

From the immune system, arnica components have a moderate modulating effect, suppressing hyperactive phases of the inflammatory cascade and promoting the transition to the repair phase. At the same time, a direct immunosuppressive effect has not been detected, which makes the action regulating, not suppressing.

Essential oils (including thymol and other terpene structures) exhibit antimicrobial activity against a number of gram-positive bacteria and fungi, which enhances the anti-infective potential with local use. Their effect may be associated with a violation of the integrity of microbial membranes and suppression of the growth of microbial biofilm.

The neurotropic effect of arnica is manifested in a moderate decrease in the sensitivity of nociceptors against the background of local application, which is associated both with a direct effect on sensory fibers and with the suppression of local release of pain mediators (prostaglandins, substance P). The potential to reduce peripheral neurogenic inflammation is also noted.

Thus, the pharmacodynamics of mountain arnica covers a multi-level and multi-component action with modulation of inflammation, microcirculation, cell regeneration, vascular tone and local antiseptic protection. The main targets are pro-inflammatory cytokines, COX-2, free radicals, the vascular wall, fibroblasts, microbial membranes and sensitive nerve endings.

References:
https://pubmed.ncbi.nlm.nih.go...
https://link.springer.com/arti...
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...

Pharmacokinetics — Arnica montana

The pharmacokinetic features of Mountain arnica (Arnica montana) largely depend on the method of application and the composition of the pharmacological form used. With external application in the form of ointments, creams, oil infusions and tinctures, the main active components — primarily sesquiterpenes, flavonoids and essential oils — penetrate through the stratum corneum of the epidermis by the transdermal route. Absorption occurs mainly under conditions of an intact skin barrier and increases with inflammation, mechanical damage and increased vascularization. The maximum localization of substances is recorded within the upper and middle layers of the dermis, with possible transcapillary diffusion into the lymphatic bed.

In the case of application to the mucous membranes of the oral cavity (rinses, compresses), the penetration of active substances is accompanied by limited systemic absorption. Components of the flavonoid group and essential oils are partially metabolized by the microflora of the oral cavity and gastrointestinal tract to phenolic metabolites, with further absorption into the bloodstream and participation of the liver in conjugation processes. The oral route of administration of arnica is not officially recommended due to its potential toxicity, however, with accidental or erroneous ingestion, absorption through the gastrointestinal tract with rapid entry into the portal system of the liver and biotransformation in hepatocytes is possible.

The metabolism of most arnica compounds occurs in the liver due to microsomal oxidation enzymes and subsequent glucuronidation and sulfation. The main metabolic products — water-soluble conjugates of flavonoids and terpenes — are excreted by the kidneys in the urine. Some components, especially hydrophobic sesquiterpenes, may undergo biliary excretion through bile, with the participation of enterohepatic circulation and possible re-entry into the bloodstream.

Excretion of essential compounds (including components of essential oil) can also occur through the skin (with sweat) and through the respiratory system in the form of volatile metabolites. With prolonged use on extensive areas of the body, accumulation of individual lipophilic components in adipose tissue is possible, especially in persons with overweight or reduced liver function. However, with standard external use, systemic accumulation is minimal and clinically insignificant.

The features of transdermal transport of the taxon are determined not only by the physicochemical properties of the substances themselves, but also by the composition of the base (oil or emulsion), which affects the depth of penetration. Oil forms contribute to longer release and local concentration of active substances in the skin and subcutaneous adipose tissue, while water-alcohol forms provide faster release and short-term action. Bioavailability in the systemic circulation with external and local use remains extremely low, which determines their safety when observing the dosage regimen.

References:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358860/
https://www.sciencedirect.com/science/article/abs/pii/S0378874110000400
https://pubmed.ncbi.nlm.nih.gov/21373368/
https://link.springer.com/article/10.1007/s11418-015-0903-3

Mechanisms of Action and Scientific Rationale — Arnica montana

The pharmacological activity of mountain arnica (Arnica montana) is due mainly to the presence of sesquiterpene lactones, flavonoids, phenolic acids and essential oils, each of these groups having a specific effect on molecular and cellular targets. The sesquiterpene helenalin, which is the main biologically active component, has a modulating effect on inflammatory cascades by irreversibly inhibiting transcription factors, in particular, suppressing the activation of the NF-κB complex. This leads to a decrease in the expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), as well as to the suppression of the synthesis of the enzymes cyclooxygenase-2 (COX-2) and lipoxygenase (5-LOX), which are involved in the metabolism of arachidonic acid and the production of prostaglandins and leukotrienes.

Flavonoids, represented mainly by quercetin, isorhamnetin and their glycosides, have an antioxidant and stabilizing effect on cell membranes. They block reactive oxygen species (ROS) and prevent lipid peroxidation, while simultaneously suppressing the activation of caspases in macrophages and epithelial cells. This helps to reduce apoptosis, reduce tissue damage and restore redox balance. Additionally, flavonoids inhibit the MAPK and JNK signaling pathways involved in the transmission of inflammatory stimuli from receptors to the cell nucleus.

Essential components, including mono- and sesquiterpenes, exhibit antimicrobial action by destabilizing the lipid bilayer of bacterial membranes, disrupting permeability and ionic gradients. This disrupts the viability of microorganisms, including resistant forms. Some components of essential oils affect calcium channels in sensory endings, weakening their excitability and reducing the perception of pain impulses.

Coumarins and phenolic acids present in arnica exhibit vascular-protective properties through inhibition of hyaluronidase activity and reduction of vascular wall permeability. They stabilize the endothelium, reduce plasma transudation and activate lymphatic outflow, including by increasing the tone of smooth muscle cells of venules. The effect on the endothelium is accompanied by an increase in the expression of vascular growth factors (VEGF) and an increase in reparative processes.

In addition, arnica extracts affect the functional activity of neutrophils and macrophages. In vitro studies show a decrease in migration, phagocytic activity and production of oxidative metabolites by these cells. This may be associated with modulation of the JAK/STAT and PI3K/Akt signaling pathways involved in cytokine signal transduction and cell cycle regulation. The ability of arnica to reduce the expression of adhesion molecules on the surface of the vascular endothelium, such as ICAM-1 and VCAM-1, which prevents leukocyte extravasation into the focus of inflammation, has also been described.

Thus, the total effect of the biocomplex of mountain arnica is realized through a multi-level effect on inflammatory mediators, oxidative stress, microbial activity and vascular reactivity, including the regulation of transcription factors, ion channels, receptors and enzymes. These mechanisms are confirmed by data from cellular and molecular models, as well as by comparative pharmacodynamic observations.

References:
https://pubmed.ncbi.nlm.nih.go...
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://link.springer.com/arti...

Synergy — Arnica montana

The pharmacological synergy of mountain arnica (Arnica montana) with other plant and natural substances is being actively studied in the context of anti-inflammatory, analgesic, antioxidant and antimicrobial action. It has been confirmed that the combination of arnica with plants containing flavonoids and phenolic compounds (for example, calendula, witch hazel, chamomile) has a potentiating effect on the modulation of inflammatory cascades, especially through the suppression of the expression of pro-inflammatory cytokines (TNF-α, IL-1β) and the inhibition of cyclooxygenase (COX-2) activity. In vitro studies have revealed an additive effect with the simultaneous action of arnica and witch hazel extracts on the suppression of the production of inflammatory mediators by macrophages.

The combined use of arnica with substances rich in terpenoid and essential structures, such as peppermint and lavender, demonstrates a synergistic enhancement of the local analgesic effect due to the combined action on TRPV1 and calcium channels of sensory neurons. These substances complement the peripheral desensitization of pain receptors, and also contribute to local vasodilation and increased lymph drainage, which may explain the tissue-specific reduction of edema and tension.

Flavonoid complexes (in particular, arnica in combination with rutoside or quercetin) demonstrate a potentiating antioxidant effect when incubated with vascular endothelial cells. It was found that this combination reduces the level of intracellular ROS and enhances the expression of antioxidant defense enzymes (SOD, GPx). This interaction is considered as a cellular mechanism for stabilizing the endothelium and reducing its permeability under conditions of oxidative stress.

In vivo evidence shows that the combination of arnica with allantoin and panthenol with external use has a modulating effect on the tissue regeneration phase, enhancing fibroblast proliferation and accelerating re-epithelialization. The effect is additive and is realized through an effect on the production of growth factors (in particular, TGF-β1) and the acceleration of collagen formation. This interaction has a tissue-specific orientation and is relevant for damage to the skin.

Synergy between arnica and essential oils of tea tree or thyme has also been noted in terms of antimicrobial action. The combined effect demonstrates increased inhibition of the growth of gram-positive bacteria and Candida fungi due to the joint destruction of the membrane structure of the pathogen and the inhibition of enzymes of the microbial biofilm. This is confirmed by microbiological models using isolates of Staphylococcus aureus and Candida albicans.

In addition, there is evidence of a protective interaction of arnica with natural antioxidants such as tocopherol (vitamin E) when applied against the background of oxidative tissue damage. Combined use reduces the level of lipid peroxidation and stabilizes the level of glutathione in tissues, providing systemic and cellular antioxidant cover.

Thus, the pharmacological synergy of mountain arnica is realized through several mechanisms — from co-inhibition of inflammatory mediators to enhancement of regenerative and antioxidant processes at the tissue and cellular levels. The nature of the interaction varies from potentiating to additive and can be used in complementary phytoformulas, provided that compatibility is confirmed.

References:
https://www.ncbi.nlm.nih.gov/p...
https://pubmed.ncbi.nlm.nih.go...
https://www.sciencedirect.com/...
https://link.springer.com/arti...

Geography of Use and Traditional Medicine — Arnica montana

Arnica montana is traditionally used in the folk medicine of European regions, especially in the mountainous and subalpine zones of Central and Southern Europe, including Germany, Austria, France, Switzerland, Poland, the Czech Republic, as well as Scandinavia and the western regions of Ukraine and Russia. The first documented mentions of the use of arnica are found in German herbalists of the 16th century, including the works of Hieronymus Bock and Jacob Theodor Tabernaemontanus, where the plant was described as an external remedy for bodily injuries. In the tradition of Alpine shamanism, arnica was considered the "herb of mountain shepherds" and was widely used in the form of alcohol tinctures, poultices and compresses.

In German-speaking ethnomedical practices, arnica was used externally in the form of decoctions and homemade ointments, often in combination with beeswax and fat. Its use was associated with bodily "fatigue", as well as with the "outflow of bad juices" from bruised tissues. In Slavic folk medicine, including the Carpathian and Balkan regions, arnica was part of preparations for wraps, lotions and bath decoctions. In some West Slavic and Polish villages, the plant was used in rituals of cleansing the dwelling — its infusion was sprinkled on thresholds, walls and beds to "ward off the evil eye and pain of the body."

In the culture of Romanian mountain communities, arnica is mentioned as the "flower of St. John" and was used in the collection of herbs on the feast of Ivan Kupala, considered a plant with cleansing and restorative power. In Celtic and Germanic pre-Christian rituals, arnica flowers were added to smoking mixtures to expel the "spirit of disease" from the house or body. Finds of Arnica montana remains in the layers of medieval monastic pharmacies (in particular, in the Alps and Bavaria) confirm its use as a component of monastic balms and tinctures.

In the healing culture of Swedish and Finnish folk healers, arnica was used in the form of warm wraps with saline solution and crushed inflorescences, which was symbolically associated with the "expulsion of cold" from joints and muscles. In some Latvian and Lithuanian villages, arnica infusion was used in ritual baths of newborns to "strengthen the spirit" and protect from the evil eye, and by shepherds — to wipe limbs after long transitions. In these traditions, arnica was considered a plant of solar energy, bringing warmth and restoration.

Non-medical and magical-ritual use of mountain arnica is mentioned in the context of Central European pagan traditions. Its dried inflorescences were often placed in amulet pouches that were worn on the body or sewn into clothing. Arnica was also added to hay for animals on the eve of the winter solstice — it was believed that the plant protects livestock from diseases and leads away "forest spirits." In some regions, arnica was included in herbal sheaves collected on the days of the summer solstice and used in rituals of purification and protection.

Thus, mountain arnica occupies an important place in the ethnobotanical traditions of Europe, combining medicinal and symbolic significance. In the cultures of many peoples, it is associated with restoration, purification, protection from invisible influences and strengthening of bodily integrity through the plant power of the mountains.